TET2 and T-cell non-Hodgkin lymphoma: Interestingly, it has been observed that phenotypically unrelated cancers such as T cell lymphomas of the angioimmunoblastic subtype and MPNs share some genetic markers such as TET2 and DNMT3a mutations that are usually considered myeloid [4,36].